More recently, PEGylated LHT7–protamine nanoparticles were used as carriers for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [72], which exhibits selective cytotoxicity to cancer cells for cancer therapeutics but has low stability and a short half-life [73,74,75]. This evidence concerns the gene TNFSF10 and cancer.